Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Myasthenia Gravis
Clinical trial register · United States · industry-sponsored

Myasthenia Gravis Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9123 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 05 Nov 2026, 03:16 UTC
9123
Studies in scope
industry-sponsored, all four open statuses
4965
Recruiting now
open to new participants
2185
Lead sponsors
across recruiting studies
Top states
California 15 Florida 13 Massachusetts 8 Kansas 7 North Carolina 7
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Myasthenia Gravis trials in the USA

20 of 9123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
TG Therapeutics, Inc.
Phase 2
120
Colorado, Florida, Michigan, North Carolina, South Carolina
2026-11-01
Recruiting
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
NCT07304154Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis
Kite, A Gilead Company
Phase 1
57
California, New York, Utah, Washington
2026-04-10
Recruiting
ImmunAbs Inc.
Phase 1/2
96
Florida, Missouri, Texas
2026-02-05
Recruiting
Janssen Research & Development, LLC
Phase 3
115
California, Colorado, Connecticut, Florida, Illinois, Indiana, Louisiana, Massachusetts
2026-01-05
Not yet open
Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
NCT07224386Myasthenia Gravis, Myasthenia Gravis, Generalized
BioSensics
Observational
50
Massachusetts
2026-01-01
Recruiting
argenx
Phase 2
70
California, Florida, Massachusetts, Michigan, Nevada, New York, North Carolina, Ohio
2025-12-19
Recruiting
argenx
Observational
70
California, Florida, Massachusetts, Michigan, Nevada, New York, North Carolina, Ohio
2025-12-19
Recruiting
ZS Associates
Observational
1,000
Illinois
2025-02-26
Recruiting
argenx
Observational
680
California, Florida, Illinois, Iowa, Kansas, Kentucky, Massachusetts, Michigan
2024-11-04
Recruiting
Kyverna Therapeutics
Phase 2/3
66
California, Florida, Indiana, Missouri, Oregon, Pennsylvania, Texas, Utah
2024-08-28
Recruiting
Vitaccess Real MG Registry
NCT06064461Myasthenia Gravis
Vitaccess Ltd
Observational
600
California, Illinois, Kentucky, New Jersey, South Carolina, Texas
2024-07-31
Active, closed
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
NCT06106672Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis, MuSK MG
COUR Pharmaceutical Development Company, Inc.
Phase 1/2
54
Arizona, California, Connecticut, Florida, Illinois, Kansas, Michigan, Missouri
2024-05-30
Recruiting
NMD Pharma A/S
Phase 2
84
California, Colorado, Florida, Georgia, Missouri, North Carolina, Ohio, Oregon
2024-05-16
Active, closed
argenx
Phase 3
119
Arizona, California, Florida, Georgia, Kansas, New Jersey, North Carolina, Ohio
2024-04-16
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Alabama, California, Colorado, Connecticut, Kansas, Massachusetts, Missouri, New Jersey
2024-03-28
Recruiting
argenx
Observational
279
West Virginia
2023-11-30
Active, closed
SP Thoracic IDE Study
NCT05150210Primary Lung Cancer, Benign Lung Disease, Thymoma, Myasthenia Gravis
Intuitive Surgical
Not applicable
32
California, Massachusetts, New York, North Carolina, Texas
2022-07-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
12
Arizona, California, Colorado, Florida, Kansas, Michigan, Pennsylvania
2022-07-20
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Arizona, California, Colorado, Connecticut, Florida, Georgia, Kansas, Massachusetts
2021-07-15
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
California, Connecticut, District of Columbia, Florida, Kansas, North Carolina, Ohio, Pennsylvania
2020-10-15
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 5 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/myasthenia-gravis

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,123 studies in total at the last sync on 05 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Myasthenia Gravis.

How many Myasthenia Gravis trials are recruiting in the US?

14 of the 20 studies on this page are recruiting new participants as of the 05 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Myasthenia Gravis), 20 studies
PhaseStudiesRecruitingShare
Observational6530%
Phase 34220%
Phase 23315%
Phase 12110%
Phase 1/22110%
Phase 2/32210%
Not applicable105%

Most active sponsors

Lead sponsors with the most studies (Myasthenia Gravis)
Lead sponsorStudiesRecruiting
argenx54
Janssen Research & Development, LLC33
Amgen10
BioSensics10
COUR Pharmaceutical Development Company, Inc.10
ImmunAbs Inc.11
Intuitive Surgical10
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company10
Kite, A Gilead Company11
Kyverna Therapeutics11

Top states

Top states (Myasthenia Gravis), by number of studies with a site there
StateStudies
California15
Florida13
Massachusetts8
Kansas7
North Carolina7
Colorado6
Michigan6
Connecticut5
Illinois5
Missouri5
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.